Recent ARTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 10:16:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/07/2026 09:05:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 09:17:04 PM
- Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate • GlobeNewswire Inc. • 12/23/2025 02:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/11/2025 09:14:35 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/11/2025 09:05:26 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical • GlobeNewswire Inc. • 12/03/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:05:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2025 09:56:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:01:01 PM
- Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/12/2025 01:00:00 PM
- Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer • GlobeNewswire Inc. • 11/04/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 12:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 12:00:51 PM
- Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer • GlobeNewswire Inc. • 10/27/2025 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/21/2025 09:48:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2025 08:30:34 PM
- Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid & Endocannabinoid Drug Development Summit • GlobeNewswire Inc. • 10/15/2025 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:28:39 PM
- Artelo Biosciences Announces Closing of $2.0 Million Public Offering • GlobeNewswire Inc. • 10/01/2025 08:05:00 PM
Metavesco Congratulates DeFi Dev Corp on Becoming the Second Publicly Traded Company to Launch a Memecoin • MVCO • Jan 22, 2026 6:04 PM
Rainmaker Worldwide Strengthens North American Growth Pipeline With Affiliate Partnership Supporting Ontario's Housing Expansion • RAKR • Jan 22, 2026 10:19 AM
From Permits to Gold Pour: Why Readiness Matters • LFLR • Jan 22, 2026 9:00 AM
Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro's 2026 Product Catalog • BLOZF • Jan 22, 2026 8:52 AM
Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process • EVTV • Jan 21, 2026 1:25 PM
Rainmaker Worldwide Expands U.S. Operations With ATMOCELL 5K and R/OCell® Deployments in the Permian Basin • RAKR • Jan 20, 2026 11:15 AM
